Breakfast Panel: Interactive Molecular Tumor Board

This event, co-produced by Precision Oncology News and the Precision Medicine Leaders’ Summit, is an interactive, in-person version of the Precision Oncology News Virtual Molecular Tumor Board Series, now in its third year.

Like the virtual series, the in-person Interactive Molecular Tumor Board highlights the key role that molecular tumor boards play in implementing precision oncology. This session will focus on the clinical impact that comprehensive genomic profiling can have on solid tumor treatment selection.

This breakfast session will take place in Chicago during the annual meeting of the American Society of Clinical Oncology, providing an intimate setting to engage with leading oncologists and pharmaceutical executives at the leading edge of precision oncology.

Our multidisciplinary panel of experts will review the genomic and clinical evidence for various anonymized cancer patients who have had their tumors sequenced as part of clinical management. The panel will then discuss each case and recommend a course of treatment. Questions and comments from the audience will be encouraged throughout the discussion.

This panel will be chaired by Howard McLeod PharmD, FASCO, FCCP, Executive Clinical Director, Precision Health at Intermountain Healthcare. Our panelists are Noor Naffakh, PharmD, MS, Hematology and Oncology Clinical Pharmacist and an Assistant Professor at the University of Illinois College of Pharmacy, Porscha Johnson Williams, PharmD, Medical Oncology Clinical Pharmacy Specialist at Northside Hospital of Atlanta, Ryan Nguyen, DO, Medical Oncologist and Assistant Professor of Clinical Medicine at the University of Illinois at Chicago and Natalie Reizine, MD, Medical Oncologist at the University of Illinois Health.

*This event is in-person only and will not be made available virtually.